AMV: American Vietnamese Biotech Incorporation - Summary | Jitta

American Vietnamese Biotech Incorporation

VNM:AMV

Price
₫1,700.00
Loss Chance
58.4%
0.51JITTA SCORE
100.00%Over Jitta Line
Jitta Ranking
612 / 622
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (15)
Recent Business Performance (22)
Financial Strength (55)
Return to Shareholders (5)
Competitive Advantage (16)
Jitta Signs
Revenue and EarningEarning loss detected in 2025
Operating MarginDeclined
Recent Business PerformanceEarning decline 105.62% in the last quarter (yoy)
New Share IssuedMore than 50% in 5 years
SG&A to SalesIncreasing
Cash Conversion CycleMore than 1 year
Key Stats
Jitta Score
Jitta Line
0.51
100.00%
3.94
171.55%
COMPANY DESCRIPTION
American Vietnamese Biotech Incorporation engages in the pharmaceutical business in Vietnam. The company offers bio-medical diagnostic products; develops centralized diagnosis center; and supplies medical equipment, machinery, and testing chemicals. It offers air water equipment, medicine labelling machine, heath dry film, medical dry film printer, price detector, mobile X-ray machine, panoramic dental camera, industrial and electrical pump, automatic molecular biology analyzer, automated immunoassay machine and chemical machines, and ozone endoscope washing machine. American Vietnamese Biotech Incorporation was founded in 2002 and is headquartered in Ho Chi Minh City, Vietnam.